BioSpace News Archive

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company recognized significant growth across the business in 2019.

Advanced ICU Care, the nation’s leading provider of high-acuity telemedicine services, announced that The Regional Medical Center (RMC), a non-profit hospital providing leading-edge care in Orangeburg, SC, has implemented the company’s tele-ICU care services.

Pinnacle Treatment Centers, a leader in providing accessible treatment for adult men and women struggling with substance use disorder, will open Georgetown Treatment Services, Ohio’s first medication unit, on Monday

Youngevity International, Inc. (NASDAQ: YGYI), a leading multi-channel lifestyle company, today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (NASDAQ:YGYIP) for each of January, February and March 2020.

Seneca Biopharma, Inc. (Nasdaq:SNCA), today announced the agreement by several accredited investors to exercise certain warrants to purchase up to an aggregate of 5,555,554 shares of common stock having an exercise price of $2.70 issued by the company on July 30, 2019,

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced Call-in details for the upcoming investor conference call on Tuesday January 21, 2020 at 9:30 AM Eastern time.

Halo Labs Inc. (“Halo” or the “Company”) (OTCQX:AGEEF), wishes to make the following statements regarding recent market activity concerning its common shares (the “Common Shares”) traded on the OTCQX marketplace.

T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it issued an inducement award to John Sperzel, the Company’s recently appointed Chief Executive Officer and President,

Health Canada is advising Canadians that Pharmascience Inc. is recalling one lot of PMS-Nystatin Oral Suspension, because it may contain clumps or jelly-like material that may pose a choking risk

Urovant Sciences (Nasdaq: UROV) announced today that Chief Executive Officer Keith Katkin and other Urovant executives will ring the opening bell of the Nasdaq Stock Market on Tuesday, January 21, 2020, at 9:30 a.m. Eastern.